| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/13/2008 | US7371415 Method and composition for improving sexual fitness |
| 05/13/2008 | US7371395 Vaccine formulations |
| 05/13/2008 | US7371394 Antigenic composition of a Pseudomonas aeruginosa protein |
| 05/13/2008 | US7371393 Methods for reducing fecal shedding |
| 05/13/2008 | US7371392 Cd40 ligand adjuvant for respiratory syncytial virus |
| 05/13/2008 | US7371391 Papilloma virus capsomere vaccine formulations and methods of use |
| 05/13/2008 | US7371390 Vaccine of a hepatitis B viral (HBV) antigen and a human papillomavirus (HPV) antigen with an adjuvant which is a preferential stimulator of TH1 cell response such as QS21 (a Quillaja saponaria saponin); free of a herpes simplex viral antigen; vaccine for adolescents e.g. against cervical cancer |
| 05/13/2008 | US7371388 Treatment of Sjogren's syndrome by administration of TR18 polypeptides |
| 05/13/2008 | US7371387 An in-frame translation fusion of an antigen with an antigen presenting cell binding domain of an opsonin forms a fusion polypeptide which when adminstered to a patient moldulates an immune response to the antigen |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371385 Method of treating immune pathologies with low dose estrogen |
| 05/13/2008 | US7371384 Compositions and methods of using angiopoietin-like 4 protein antibody |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371381 Anti-galanin antibodies and uses thereof |
| 05/13/2008 | US7371380 Anti-Cark antibodies and uses therefor |
| 05/13/2008 | US7371379 Epidermal growth factors (ErbB2); gene expression inhibition; anticancer agents |
| 05/13/2008 | US7371378 Anticancer agents; genetic engineering; monoclonal antibodies |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371376 Bind to epitope and induce apoptosis; gene expression and vinorelbine to treat breast cancer |
| 05/13/2008 | US7371371 Interleukin-2 mutants with reduced toxicity |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2223438C Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 05/13/2008 | CA2216658C Hapten-carrier conjugates for use in drug-abuse therapy |
| 05/13/2008 | CA2183435C Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
| 05/13/2008 | CA2139655C Deletion mutants as vaccines for cholera |
| 05/08/2008 | WO2008055069A2 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 05/08/2008 | WO2008054892A2 Chitin micro-particles as an adjuvant |
| 05/08/2008 | WO2008054535A2 Novel influenza m2 vaccines |
| 05/08/2008 | WO2008054532A2 Compositions and methods for treating anthrax lethality |
| 05/08/2008 | WO2008054523A2 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 05/08/2008 | WO2008054517A2 Immunosuppressant binding antibodies and methods of obtaining and using same |
| 05/08/2008 | WO2008053579A1 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 05/08/2008 | WO2008053573A1 Remedy for malignant neoplasm |
| 05/08/2008 | WO2008053055A1 Prophylactic tuberculosis vaccine |
| 05/08/2008 | WO2008052798A2 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/08/2008 | WO2008052796A1 Fgfr4 antibodies |
| 05/08/2008 | WO2008052740A2 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours |
| 05/08/2008 | WO2008036254A3 Autophagic compounds and tyrosine kinase inhibitors for treating cancer |
| 05/08/2008 | WO2008033105A8 Hemagglutinin antibody and uses thereof |
| 05/08/2008 | WO2008009652A3 Vaccines for malaria |
| 05/08/2008 | WO2008009088A3 Vaccine composition and immunization method |
| 05/08/2008 | WO2007146172A3 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 05/08/2008 | WO2007144903A3 A hybrid cell vaccine against leishmaniasis [kala-azar] |
| 05/08/2008 | WO2007143689A8 Compositions and methods for modulating vascular development |
| 05/08/2008 | WO2007112403A3 Prevention and treatment of ischemia-reperfusion injury |
| 05/08/2008 | WO2007095530A3 Diagnostic kits to detect sp22 and sp22 antibodies |
| 05/08/2008 | WO2007081583A8 Anti-pneumococcal preparations and methods of use |
| 05/08/2008 | WO2007063421A3 Compositions and methods relating to treatment of cancer and infectious diseases |
| 05/08/2008 | WO2007050359A8 Anti-addl monoclonal antibody and use thereof |
| 05/08/2008 | WO2007039070A8 Polynucleotides of haemophilus parasuis and its use |
| 05/08/2008 | WO2007008092A3 Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus |
| 05/08/2008 | WO2006076691A8 Irta-2 antibodies and their uses |
| 05/08/2008 | WO1999048916A8 Hypoxia-inducible human genes, proteins, and uses thereof |
| 05/08/2008 | US20080109654 System and method for RFID transfer of MAC, keys |
| 05/08/2008 | US20080108585 Dna vaccination for treatment of autoimmune disease |
| 05/08/2008 | US20080108561 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 05/08/2008 | US20080108107 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 05/08/2008 | US20080107763 Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
| 05/08/2008 | US20080107762 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 05/08/2008 | US20080107694 Glycolic acid-lactic acid copolymer; biocompatible; biodegradable; RNA interference; inhibitors of vascular endothelial growth factor (VEGF); ocular disorders |
| 05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
| 05/08/2008 | US20080107692 Fusion proteins; immunogens; host cells; diagnostic kits |
| 05/08/2008 | US20080107691 Vibrio cholerae strains vcusm1 and vcusm4, method of producing same, and vaccine derivatives thereof |
| 05/08/2008 | US20080107690 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treating wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne |
| 05/08/2008 | US20080107689 Stable Microbial Inoculants and Methods for Production of Them |
| 05/08/2008 | US20080107688 Virulent systemic feline calicivirus |
| 05/08/2008 | US20080107687 Recombinant poxvirus vectors encode and express antigens, epitopes or immunogens; immunology |
| 05/08/2008 | US20080107686 Such as granulocyte-macrophage colony stimulating factor; cytokines; kits; capsules |
| 05/08/2008 | US20080107685 Serotypes produced by site directed mutagenesis; immunogens; vaccines |
| 05/08/2008 | US20080107684 Immunotherapy; hypersensitivity; antiinflammatory agents; autoimmune disorders |
| 05/08/2008 | US20080107683 Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof |
| 05/08/2008 | US20080107682 Brucella melitensis mutants and methods |
| 05/08/2008 | US20080107681 Recombinant poxvirus vectors encode and express antigens, epitopes or immunogens; immunology |
| 05/08/2008 | US20080107680 Linked to polyoxyethylene glycol via oximination |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107673 Clostridial polypeptide for use in prevention and treatment of microorganismal infcetion |
| 05/08/2008 | US20080107672 Mutant viral antigen for use in diagnosing hepatitis; immunoassay |
| 05/08/2008 | US20080107671 Vaccine comprising yeast vehicle and hepatitis c viral protease fusion for use in prevention and treatment of viral disease |
| 05/08/2008 | US20080107670 Antigenic peptides based on gag protein conserved regions for use in treatment and prevention of viral infection; viricides |
| 05/08/2008 | US20080107669 Antigenic peptides based on gag protein conserved regions for use in treatment and prevention of viral infection; viricides |
| 05/08/2008 | US20080107668 Oligopeptides comprising epitopic sequences for use in induction of killer lymphocyte response in treatment of cell proliferative disorders |
| 05/08/2008 | US20080107667 Fusion peptide for use in targeting cells for lympocytic destruction; immunotherapy |
| 05/08/2008 | US20080107666 Non-Glycosylated Recombinant Collagen-Like Polypeptides |
| 05/08/2008 | US20080107665 Immungenic composition for prevention and treatment of tetanus |
| 05/08/2008 | US20080107664 Using mylein basic protein to prepare vaccine for treatment of autoimmune disease |
| 05/08/2008 | US20080107663 Tri1 Cells for Use in Atherosclerosis |
| 05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
| 05/08/2008 | US20080107661 Using cell free system for identifying agents which prevent mucin and chronic myelogenous leukemia ligand binding; antitumor agents; treating cell proliferative, nervous system, inflammatory and atherosclerotic disorders |
| 05/08/2008 | US20080107660 Binding Agents |
| 05/08/2008 | US20080107659 Pharmaceutical Compositions for the Prevention and Treatment of Atherosclerosis and Restenosis After PTCA |
| 05/08/2008 | US20080107658 Nerve growth specific chimerikc ligand comping immunoglobulin component for use in treatment and prevention of arthritic, skin, viral, inflammatory, respiratory and pain disorders |
| 05/08/2008 | US20080107657 Antibodies that bind to an epitope on the huntington's disease protein |
| 05/08/2008 | US20080107656 Plasmodium specific immunoglobulin for use in prevention and treatment of parasitic infection; parasiticides |
| 05/08/2008 | US20080107655 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 05/08/2008 | US20080107654 Immunloglobulin specific for calcium transport membrane protein for use in prevention and treatment of hematological disorders |